NEW YORK (GenomeWeb News) – Sequenom filed a prospectus today with the US Securities and Exchange Commission to sell 5.5 million shares of common stock through the open market.
 
The San Diego-based firm said that it expects to realize net proceeds of around $73.4 million, assuming an offering price of $14.25 per share, which was its closing price on the Nasdaq on Friday.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.